Miyagi, E., Opi, S., Takeuchi, H., Khan, M., Goila-Gaur, R., Kao, S., & Strebel, K. (2007). Enzymatically Active APOBEC3G Is Required for Efficient Inhibition of Human Immunodeficiency Virus Type 1. American Society for Microbiology (ASM).

Miyagi, Eri, Sandrine Opi, Hiroaki Takeuchi, Mohammad Khan, Ritu Goila-Gaur, Sandra Kao, und Klaus Strebel. Enzymatically Active APOBEC3G Is Required for Efficient Inhibition of Human Immunodeficiency Virus Type 1. American Society for Microbiology (ASM), 2007.

Miyagi, Eri, et al. Enzymatically Active APOBEC3G Is Required for Efficient Inhibition of Human Immunodeficiency Virus Type 1. American Society for Microbiology (ASM), 2007.